Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing ethical standards in Göttingen Minipigs studies: The feasibility and reliability of Vascular Access Buttons™.

Laboratory animals·2025
Same author

Dose level selection for developmental and reproductive toxicology (DART) studies: Insights from the EUROTOX 2024 satellite workshop.

Regulatory toxicology and pharmacology : RTP·2025
Same author

EU roadmap for phasing out animal testing for chemical safety assessments: Recommendations from a multi-stakeholder roundtable.

ALTEX·2025
Same author

Is there any added value of the second generation in the Extended One-Generation Reproductive Toxicity Study (EOGRTS)? A retrospective analysis of 24 EOGRTS.

Reproductive toxicology (Elmsford, N.Y.)·2024
Same author

There is no need for overnight fasting of rats in regulatory toxicology studies.

Toxicology·2024
Same author

Review of dose setting for the extended one-generation reproductive toxicity studies (OECD TG 443): Considerations on ECHA's dose level selection recommendations.

Regulatory toxicology and pharmacology : RTP·2024

Related Experiment Video

Updated: Jan 13, 2026

Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
02:52

Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae

Published on: March 7, 2025

2.0K

Zebrafish Embryo Developmental Toxicity Assay (ZEDTA) for Regulatory Testing-Protocol Optimization and Historical

Daphne van den Oetelaar1,2, Marysia Agnieszka Tobor-Kapłon3, Mèlanie Reijnaers1,2

  • 1Developmental and Reproductive Toxicology, Charles River Laboratories, 5231 DD 's-Hertogenbosch, The Netherlands.

Toxics
|October 28, 2025
PubMed
Summary
This summary is machine-generated.

The optimized Zebrafish Embryo Developmental Toxicity Assay (ZEDTA) protocol provides reliable control data for preclinical teratogenicity testing. This method ensures low mortality and minimal spontaneous malformations, supporting regulatory acceptance.

Keywords:
historical control dataoptimizationteratogenicityzebrafishzebrafish embryo developmental toxicity assay (ZEDTA)

More Related Videos

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos
07:49

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos

Published on: August 25, 2019

11.5K
Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.1K

Related Experiment Videos

Last Updated: Jan 13, 2026

Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
02:52

Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae

Published on: March 7, 2025

2.0K
Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos
07:49

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos

Published on: August 25, 2019

11.5K
Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.1K

Area of Science:

  • Developmental toxicology
  • Preclinical drug safety assessment
  • Alternative testing methods

Background:

  • The Zebrafish Embryo Developmental Toxicity Assay (ZEDTA) shows promise for replacing mammalian teratogenicity screening.
  • A lack of harmonized protocols and accessible background data hinders ZEDTA's current regulatory use.
  • Standardization is crucial for the validation and acceptance of ZEDTA in preclinical development.

Purpose of the Study:

  • To optimize the ZEDTA protocol for reliable developmental toxicity testing.
  • To generate historical control data for spontaneous malformation incidence.
  • To establish a robust assay for teratogenic substance screening.

Main Methods:

  • Zebrafish larvae were exposed in 24-well plates at 26°C with solution renewal every 48 hours.
  • 0.5% v/v DMSO was used as a solvent control, showing no increased toxicity compared to ISO medium.
  • 26 valid experiments were conducted using the refined ZEDTA protocol.

Main Results:

  • The optimized ZEDTA protocol resulted in 3.5% overall mortality after 96 hours of exposure.
  • Spontaneous malformations occurred in 7.6% of surviving larvae, with yolk sac deformation being most common (4.0%).
  • Low background malformation rates and mortality indicate a reliable assay.

Conclusions:

  • The optimized ZEDTA protocol effectively supports zebrafish larval development with minimal confounding factors.
  • The generated historical control data enhance the reliability and reproducibility of the assay.
  • This research is a significant step toward global harmonization and regulatory acceptance of ZEDTA.